452 related articles for article (PubMed ID: 22560299)
21. Treatment of chronic gouty arthritis: it is not just about urate-lowering therapy.
Schlesinger N
Semin Arthritis Rheum; 2012 Oct; 42(2):155-65. PubMed ID: 22542277
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis and Clinical Management of Gouty Arthritis.
Saigal R; Agrawal A
J Assoc Physicians India; 2015 Dec; 63(12):56-63. PubMed ID: 27666904
[TBL] [Abstract][Full Text] [Related]
23. Urate-lowering efficacy and renal safety of febuxostat in patients with hyperuricemia and stage 4-5 chronic kidney disease not yet on dialysis: A meta-analysis of observational studies.
Jeong HJ; Park WY; Kim SH; Dalbeth N; Son CN
Semin Arthritis Rheum; 2022 Oct; 56():152073. PubMed ID: 35914389
[TBL] [Abstract][Full Text] [Related]
24. [Gout: an overview of available urate lowering therapies].
Richette P
Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
[TBL] [Abstract][Full Text] [Related]
25. Long-term management of gout: nonpharmacologic and pharmacologic therapies.
Chaichian Y; Chohan S; Becker MA
Rheum Dis Clin North Am; 2014 May; 40(2):357-74. PubMed ID: 24703352
[TBL] [Abstract][Full Text] [Related]
26. Comparison of long-term efficacy and renal safety of febuxostat and allopurinol in patients with chronic kidney diseases
.
Yang AY
Int J Clin Pharmacol Ther; 2020 Jan; 58(1):21-28. PubMed ID: 31657714
[TBL] [Abstract][Full Text] [Related]
27. An update on the treatment options for gout and calcium pyrophosphate deposition.
Choy G
Expert Opin Pharmacother; 2005 Nov; 6(14):2443-53. PubMed ID: 16259576
[TBL] [Abstract][Full Text] [Related]
28. Pegloticase for treating refractory chronic gout.
George RL; Sundy JS
Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
[TBL] [Abstract][Full Text] [Related]
29. Comorbidities in gouty arthritis.
Marwah RK
J Investig Med; 2011 Dec; 59(8):1211-20. PubMed ID: 22064605
[TBL] [Abstract][Full Text] [Related]
30. Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4-5 chronic kidney disease not yet on dialysis.
Kim SH; Lee SY; Kim JM; Son CN
Korean J Intern Med; 2020 Jul; 35(4):998-1003. PubMed ID: 30959584
[TBL] [Abstract][Full Text] [Related]
31. Treatment of acute gout: a systematic review.
Khanna PP; Gladue HS; Singh MK; FitzGerald JD; Bae S; Prakash S; Kaldas M; Gogia M; Berrocal V; Townsend W; Terkeltaub R; Khanna D
Semin Arthritis Rheum; 2014 Aug; 44(1):31-8. PubMed ID: 24650777
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of gout].
Dubost JJ; Mathieu S; Soubrier M
Rev Med Interne; 2011 Dec; 32(12):751-7. PubMed ID: 21382654
[TBL] [Abstract][Full Text] [Related]
33. [Gout and hyperuricaemia--should both be treated?].
Uhlig T
Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2878-80. PubMed ID: 14600714
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in management of gout.
Suresh E; Das P
QJM; 2012 May; 105(5):407-17. PubMed ID: 22198943
[TBL] [Abstract][Full Text] [Related]
35. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
[TBL] [Abstract][Full Text] [Related]
36. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
[TBL] [Abstract][Full Text] [Related]
37. Febuxostat: a new treatment for hyperuricaemia in gout.
Edwards NL
Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii15-ii19. PubMed ID: 19447778
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease
.
Kwak CH; Sohn M; Han N; Cho YS; Kim YS; Oh JM
Int J Clin Pharmacol Ther; 2018 Jul; 56(7):321-327. PubMed ID: 29750634
[TBL] [Abstract][Full Text] [Related]
39. Advances in the management of gout and hyperuricaemia.
Hoskison TK; Wortmann RL
Scand J Rheumatol; 2006; 35(4):251-60. PubMed ID: 16882587
[TBL] [Abstract][Full Text] [Related]
40. Prophylaxis of acute flares when initiating febuxostat for chronic gouty arthritis in a real-world clinical setting.
Yu J; Qiu Q; Liang L; Yang X; Xu H
Mod Rheumatol; 2018 Mar; 28(2):339-344. PubMed ID: 28485997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
